The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Pyxis Oncology, Inc.(NASDAQ:PYXS)


Pyxis Oncology, Inc., a preclinical stage biotechnology company, engages in the development of antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies to treat cancers. Its preclinical products pipeline includes PYX-201, a site-specific investigational ADC targeting onco-fetal ...
Share this website to your friends
Pyxis Oncology . Days Payable Outstanding ttm (DPO)
Pyxis Oncology . Op Cashflow Per Share ttm
Pyxis Oncology . Free Cashflow Per Share ttm
Pyxis Oncology . Cash Per Share ttm
Pyxis Oncology . (GAAP) P/E ratio ttm
Pyxis Oncology . P/B ratio ttm
No extra charts and metrics for this ticker.